Literature DB >> 15578467

Arterial versus venous sampling for activated coagulation time measurements during cardiac surgery: a comparative study.

Galina Leyvi1, Ilya Zhuravlev, Asuquo Inyang, Joselito Vinluan, Sujatha Ramachandran, Ellen J Lehning, John D Wasnick.   

Abstract

OBJECTIVE: Activated coagulation times (ACTs) are widely used for monitoring anticoagulation during cardiac surgery. Significant variability of this test is well known. Variability in test results was studied, which may arise from the sample drawing site.
DESIGN: Prospective study.
SETTING: University hospital. PARTICIPANTS: Sixty-five patients scheduled for surgery requiring cardiopulmonary bypass were enrolled in the study. INTERVENTION: ACTs were assessed using the Hemochron 801 ACT machine. Samples were collected (1) baseline I from the arterial catheter before anesthetic induction, (2) baseline II from the arterial and venous collection sites after pulmonary artery catheterization, (3) after heparin administration, (4) 10 minutes after blood collection number 3, and (5) after protamine administration.
MEASUREMENTS AND MAIN RESULTS: At the baseline II, the ACT measures using venous blood were significantly higher than that obtained using an arterial sample (p = 0.001). There was no significant difference in ACT measures obtained using either arterial or venous blood samples at the other time points. After heparin administration, the ACT variability in individual patients was quite striking, with ranges of up to 600 seconds in repeated measures.
CONCLUSION: During the period of systemic anticoagulation, there is great individual variability between ACT measures obtained from venous and arterial samples. Further studies are required to analyze the cause of differences at the baseline and the source of variable coagulation times after heparin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15578467     DOI: 10.1053/j.jvca.2004.07.006

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  3 in total

1.  STS/SCA/AmSECT Clinical Practice Guidelines: Anticoagulation during Cardiopulmonary Bypass.

Authors:  Linda Shore-Lesserson; Robert A Baker; Victor Ferraris; Philip E Greilich; David Fitzgerald; Philip Roman; John Hammon
Journal:  J Extra Corpor Technol       Date:  2018-03

2.  Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling Site.

Authors:  J C Heemelaar; T Berkhout; A A C M Heestermans; J C Zant; A M J de Vos; N J W Verouden; M T Dirksen; J van Ramshorst
Journal:  J Interv Cardiol       Date:  2021-09-11       Impact factor: 2.279

3.  Comparison of Coagulation Parameters in Arterial and Venous Blood in Cardiac Surgery Measured Using the Quantra System.

Authors:  Danja S Groves; Deborah A Winegar; Lucas G Fernandez; Julie L Huffmyer; Francesco Viola
Journal:  J Cardiothorac Vasc Anesth       Date:  2018-08-31       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.